Director of the Medicines Agency was asked about the progress of studies relating to the medicine
The director general of the Italian Medicines Agency (AIFA), Nicola Magrini, said this Friday that he still there is little information about the effectiveness of hydroxychloroquine against the new coronavirus.
In a press conference in Rome, Magrini was questioned about the progress of studies related to the drug, generally used against malaria and lupus, and which is cited by Donald Trump and Jair Bolsonaro as a possible cure for Covid-19.
Read also
It will only be possible to eradicate coronavirus with a vaccine, says Italian official
Law 74/2025 is being challenged in the Court of Justice of the European Union. For thousands of descendants, the next step depends on understanding how the new rule has affected each case.
Your case may still have a legal outcome.
ANALYZE MY CASEINSS data shows that Italy had twice as many deaths from Covid-19
"We know little about its effectiveness, but we are quite sure about the possible harm and lack of safety in some limited subgroups of patients.“, declared the director of Aifa, the Italian government agency responsible for the approval of medicines.
The country's health authorities authorized tests with chloroquine and hydroxychloroquine in the treatment against the new coronavirus, but No study has produced conclusive results to date. In Brazil, the Bolsonaro government recommended its use in all types of cases, despite the lack of scientific proof of its effectiveness.
By Handle
